Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1306

1.

Using results from infectious disease modeling to improve the response to a potential H7N9 influenza pandemic.

Rasmussen SA, Redd SC.

Clin Infect Dis. 2015 May 1;60 Suppl 1:S9-10. doi: 10.1093/cid/civ090. Review.

PMID:
25878303
2.

Estimating the potential effects of a vaccine program against an emerging influenza pandemic--United States.

Biggerstaff M, Reed C, Swerdlow DL, Gambhir M, Graitcer S, Finelli L, Borse RH, Rasmussen SA, Meltzer MI, Bridges CB.

Clin Infect Dis. 2015 May 1;60 Suppl 1:S20-9. doi: 10.1093/cid/ciu1175.

PMID:
25878298
4.

Reducing mortality from emerging diseases.

[No authors listed]

Wkly Epidemiol Rec. 2015 Mar 27;90(13):121-3. English, French. No abstract available.

5.

Swine Influenza Virus PA and Neuraminidase Gene Reassortment into Human H1N1 Influenza Virus Is Associated with an Altered Pathogenic Phenotype Linked to Increased MIP-2 Expression.

Dlugolenski D, Jones L, Howerth E, Wentworth D, Tompkins SM, Tripp RA.

J Virol. 2015 May;89(10):5651-67. doi: 10.1128/JVI.00087-15. Epub 2015 Mar 11.

PMID:
25762737
6.

Diversifying Selection Analysis Predicts Antigenic Evolution of 2009 Pandemic H1N1 Influenza A Virus in Humans.

Lee AJ, Das SR, Wang W, Fitzgerald T, Pickett BE, Aevermann BD, Topham DJ, Falsey AR, Scheuermann RH.

J Virol. 2015 May;89(10):5427-40. doi: 10.1128/JVI.03636-14. Epub 2015 Mar 4.

PMID:
25741011
7.

Immunity to influenza. Preventing infection and regulating disease.

Allen EK, Thomas PG.

Am J Respir Crit Care Med. 2015 Feb 1;191(3):248-51. doi: 10.1164/rccm.201412-2245ED. No abstract available.

PMID:
25635487
8.

Validation of normal human bronchial epithelial cells as a model for influenza A infections in human distal trachea.

Davis AS, Chertow DS, Moyer JE, Suzich J, Sandouk A, Dorward DW, Logun C, Shelhamer JH, Taubenberger JK.

J Histochem Cytochem. 2015 May;63(5):312-28. doi: 10.1369/0022155415570968. Epub 2015 Jan 20.

PMID:
25604814
9.

Desialylation of airway epithelial cells during influenza virus infection enhances pneumococcal adhesion via galectin binding.

Nita-Lazar M, Banerjee A, Feng C, Amin MN, Frieman MB, Chen WH, Cross AS, Wang LX, Vasta GR.

Mol Immunol. 2015 May;65(1):1-16. doi: 10.1016/j.molimm.2014.12.010. Epub 2015 Jan 16. Review.

PMID:
25597246
10.

Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.

He W, Mullarkey CE, Duty JA, Moran TM, Palese P, Miller MS.

J Virol. 2015 Apr;89(7):3610-8. doi: 10.1128/JVI.03099-14. Epub 2015 Jan 14.

PMID:
25589655
11.

Evolution of the H9N2 influenza genotype that facilitated the genesis of the novel H7N9 virus.

Pu J, Wang S, Yin Y, Zhang G, Carter RA, Wang J, Xu G, Sun H, Wang M, Wen C, Wei Y, Wang D, Zhu B, Lemmon G, Jiao Y, Duan S, Wang Q, Du Q, Sun M, Bao J, Sun Y, Zhao J, Zhang H, Wu G, Liu J, Webster RG.

Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):548-53. doi: 10.1073/pnas.1422456112. Epub 2014 Dec 29.

12.

Longevity and determinants of protective humoral immunity after pandemic influenza infection.

Sridhar S, Begom S, Hoschler K, Bermingham A, Adamson W, Carman W, Riley S, Lalvani A.

Am J Respir Crit Care Med. 2015 Feb 1;191(3):325-32. doi: 10.1164/rccm.201410-1798OC.

PMID:
25506631
13.

Seasonal influenza vaccination is the strongest correlate of cross-reactive antibody responses in migratory bird handlers.

Oshansky CM, Wong SS, Jeevan T, Smallwood HS, Webby RJ, Shafir SC, Thomas PG.

MBio. 2014 Dec 9;5(6):e02107. doi: 10.1128/mBio.02107-14.

14.

Influenza A virus isolation, culture and identification.

Eisfeld AJ, Neumann G, Kawaoka Y.

Nat Protoc. 2014 Nov;9(11):2663-81. doi: 10.1038/nprot.2014.180. Epub 2014 Oct 16.

PMID:
25321410
15.

[Pandemic potential of circulating avian influenza strains sharing common features with the 1918 influenza strain].

Lina B.

Med Sci (Paris). 2014 Oct;30(10):851-3. doi: 10.1051/medsci/20143010011. Epub 2014 Oct 14. French. No abstract available.

16.

Pandemic 2009 H1N1 influenza in two settings in a small community: the workplace and the university campus.

Schwartz EJ, Morgan M, Lapin S.

Epidemiol Infect. 2015 Jun;143(8):1606-9. doi: 10.1017/S0950268814002684. Epub 2014 Oct 13.

PMID:
25306974
17.

NADPH oxidases as novel pharmacologic targets against influenza A virus infection.

Vlahos R, Selemidis S.

Mol Pharmacol. 2014 Dec;86(6):747-59. doi: 10.1124/mol.114.095216. Epub 2014 Oct 9. Review.

PMID:
25301784
18.

2009 H1N1 influenza and pregnancy--5 years later.

Rasmussen SA, Jamieson DJ.

N Engl J Med. 2014 Oct 9;371(15):1373-5. doi: 10.1056/NEJMp1403496. No abstract available.

PMID:
25295498
19.

Pandemic potential of avian influenza A (H7N9) viruses.

Watanabe T, Watanabe S, Maher EA, Neumann G, Kawaoka Y.

Trends Microbiol. 2014 Nov;22(11):623-31. doi: 10.1016/j.tim.2014.08.008. Epub 2014 Sep 25. Review.

PMID:
25264312
20.

Pregnant women infected with pandemic H1N1pdm2009 influenza virus displayed overproduction of peripheral blood CD69+ lymphocytes and increased levels of serum cytokines.

Cérbulo-Vázquez A, Figueroa-Damián R, Arriaga-Pizano LA, Hernández-Andrade E, Mancilla-Herrera I, Flores-Mejía LA, Arteaga-Troncoso G, López-Macías C, Isibasi A, Mancilla-Ramírez J.

PLoS One. 2014 Sep 25;9(9):e107900. doi: 10.1371/journal.pone.0107900. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk